Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This study compares the efficacy of risperidone and olanzapine to that of first-generation
antipsychotics (FGAs) in patients with schizophrenia, who failed to show a response
to initial trials of FGAs.